Summary:
Meridien Research is conducting a study of an investigational medication designed to aid with Alzheimer's Disease and Psychosis.
For more information, please call.
Qualified Participants Must:
• Be 50+ years of age
•
Have Alzheimer's disease
•
Be experiencing psychotic episodes (visual and/or auditory hallucinations, and/or delusions)
•
Have a study partner knows the individual well
Qualified Participants May Receive:
Eligible participants will receive study-related care, monitoring and study drug or placebo. Reimbursement for travel will be available to participants and their caregivers who qualify. All studies administered by a board certified physician.